Home › Funds › Millennium Management › VRTX
Millennium Management position in VRTX
VERTEX PHARMACEUTICALS INCORPORATED · Health Care
Latest position (Q2 2026)563.81K sh
Reported value held$280.06M
Portfolio Weight0.11%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 832.81K | $151.06M | New |
| Q4 2021 | 510.25K | $112.05M | Reduce |
| Q1 2022 | 422.04K | $110.14M | Reduce |
| Q2 2022 | 464.80K | $130.98M | Add |
| Q3 2022 | 66.54K | $19.27M | Reduce |
| Q4 2022 | 491.36K | $141.90K | Add |
| Q1 2023 | 284.74K | $89.71K | Reduce |
| Q2 2023 | 1.26M | $444.96M | Add |
| Q3 2023 | 846.03K | $294.20M | Reduce |
| Q4 2023 | 900.65K | $366.47M | Add |
| Q1 2024 | 497.82K | $208.09M | Reduce |
| Q2 2024 | 359.26K | $168.39M | Reduce |
| Q3 2024 | 182.19K | $84.73M | Reduce |
| Q4 2024 | 403.24K | $162.39M | Add |
| Q1 2025 | 518.24K | $251.25M | Add |
| Q2 2025 | 145.60K | $64.82M | Reduce |
| Q3 2025 | 221.74K | $86.84M | Add |
| Q4 2025 | 487.96K | $221.22M | Add |
| Q1 2026 | 182.32K | $81.41M | Reduce |
| Q2 2026 | 563.81K | $280.06M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding VRTX
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- BlackRock Inc 24.11M sh · $11.98B · Q2 2026
- Vanguard Group 24.11M sh · $10.93B · Q4 2025
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Invesco Ltd 8.04M sh · $4.00B · Q2 2026
- Geode Capital Management 6.02M sh · $2.98B · Q2 2026
- Franklin Resources 3.35M sh · $1.66B · Q2 2026
- Wellington Management Group 3.25M sh · $1.61B · Q2 2026
- Morgan Stanley 3.24M sh · $1.61B · Q2 2026
- Bank of America Corp 3.04M sh · $1.51B · Q2 2026
- Norges Bank Investment Management 2.97M sh · $1.48B · Q2 2026
- Goldman Sachs Group 2.53M sh · $1.26B · Q2 2026